Skip to main content
FDA Shortage Check

Is Xylocaine (Lidocaine Hydrochloride Injection) in shortage?

Label: plusbeauxjours · shortage label · not a prescription, not a pharmacy, not FDA

IN SHORTAGE

Xylocaine: in shortage (FDA, Oct 24)

Injections (vials)
A generic injection, not your medicine. We draw dosage forms, not products, and never pills you could match to yours.
  • Reason: “Demand increase for the drug”. FDA shortage reason (FDASIA), reported by the manufacturer
  • Reason: “Other”. FDA shortage reason (FDASIA), reported by the manufacturer
  • Estimate: “Estimated recovery: TBD”. Manufacturer’s estimate, Fresenius Kabi USA, LLC, Oct 15, 2026
DRUG
Xylocaine
FDA LISTING
FORM
injection
STATUS
Currently in Shortage
FIRST POSTED
Feb 22, 2012
LAST FDA UPDATE
Oct 21, 2026
AS OF
Oct 24, 2026
SOURCE

FDA lists 65 presentations: 19 unavailable · 1 limited · 45 available.

FDA Drug Shortages checked Oct 24, 2026, 21:05 ET · FDA updates daily · manufacturer-reported

Information from FDA’s drug shortage list, reported by manufacturers. Not medical advice. Don’t stop, change or ration a medicine without talking to your prescriber or pharmacist.

FDA's listing, word for word: Lidocaine Hydrochloride Injection. 67 presentations from 10 makers.

Check your own medication, form and strength

What to ask at the counter

  1. Is this a supply problem at this pharmacy, or everywhere? Could another pharmacy have it? FDA consumer FAQ (opens in a new tab)
  2. Is my strength or the maker you stock affected? FDA list, by presentation
  3. Is there an alternative to this medicine I should ask my prescriber about? FDA consumer FAQ (opens in a new tab)
  4. When should I check back, or can you order it?

FDA: “talk with your health care provider or pharmacist for other treatment options during the shortage.” FDA Drug Shortages page (opens in a new tab)

This listing on FDA ↗ (opens in a new tab)Report a shortage to FDA: drugshortages@fda.hhs.gov

Every presentation FDA lists, by maker

Availability is FDA's text for each package, as the manufacturer reported it. Makers with unavailable or limited packages come first.

Eugia US LLC11 presentations · 5 unavailable · 6 available or not stated

Contact (FDA's listing): 888-238-7880

  • 10 mg/1 mL

    Lidocaine Hydrochloride, Injection, 10 mg/1 mL (NDC 55150-159-74)

    On backorder. Recovery: TBD. Check wholesalers for inventory

    NDC 55150-159-74Reverified

    Unavailable

  • 10 mg/mL

    Lidocaine Hydrochloride, Injection, 10 mg/mL (NDC 55150-252-20)

    On backorder. Recovery: late October 2026; Check wholesalers for inventory

    NDC 55150-252-20Revised

    Unavailable

  • 20 mg/1 mL

    Lidocaine Hydrochloride, Injection, 20 mg/1 mL (NDC 55150-165-05)

    On backorder. Recovery: mid-November 2026; Check wholesalers for inventory

    NDC 55150-165-05Revised

    Unavailable

  • 20 mg/mL

    Lidocaine Hydrochloride, Injection, 20 mg/mL (NDC 55150-254-10)

    On backorder. Recovery: late-November 2026; Check wholesalers for inventory

    NDC 55150-254-10Revised

    Unavailable

  • 20 mg/mL

    Lidocaine Hydrochloride, Injection, 20 mg/mL (NDC 55150-256-50)

    On backorder. Recovery: TBD. Check wholesalers for inventory

    NDC 55150-256-50Reverified

    Unavailable

  • 10 mg/1 mL

    Lidocaine Hydrochloride, Injection, 10 mg/1 mL (NDC 55150-161-02)

    Check wholesalers for inventory

    NDC 55150-161-02Revised

    Available

  • 10 mg/1 mL

    Lidocaine Hydrochloride, Injection, 10 mg/1 mL (NDC 55150-162-05)

    Check wholesalers for inventory

    NDC 55150-162-05Reverified

    Available

  • 10 mg/1 mL

    Lidocaine Hydrochloride, Injection, 10 mg/1 mL (NDC 55150-163-30)

    Check wholesalers for inventory

    NDC 55150-163-30Reverified

    Available

  • 10 mg/mL

    Lidocaine Hydrochloride, Injection, 10 mg/mL (NDC 55150-251-10)

    Check wholesalers for inventory

    NDC 55150-251-10Revised

    Available

  • 20 mg/mL

    Lidocaine Hydrochloride, Injection, 20 mg/mL (NDC 55150-164-02)

    Check wholesalers for inventory

    NDC 55150-164-02Reverified

    Available

  • 20 mg/mL

    Lidocaine Hydrochloride, Injection, 20 mg/mL (NDC 55150-255-20)

    Check wholesalers for inventory

    NDC 55150-255-20Reverified

    Available

Fresenius Kabi USA, LLC20 presentations · 9 unavailable · 11 available or not stated

Contact (FDA's listing): 888-386-1300

  • 20 mg/1 mL

    Lidocaine Hydrochloride Preservative Free, Injection, 20 mg/1 mL (NDC 63323-208-05)

    Next release November 2026. Check wholesalers for inventory.

    NDC 63323-208-05Reverified

    Unavailable

  • 10 mg/1 mL

    Lidocaine Hydrochloride, Injection, 10 mg/1 mL (NDC 63323-201-10)

    Next release October 2026. Check wholesalers for inventory.

    NDC 63323-201-10Reverified

    Unavailable

  • 10 mg/1 mL

    Xylocaine, Injection, 10 mg/1 mL (NDC 63323-485-57)

    Next release October 2026. Check wholesalers for inventory.

    NDC 63323-485-57Reverified

    Unavailable

  • 10 mg/1 mL

    Xylocaine, Injection, 10 mg/1 mL (NDC 63323-492-31)

    Estimated recovery: TBD

    NDC 63323-492-31Reverified

    Unavailable

  • 15 mg/1 mL

    Xylocaine, Injection, 15 mg/1 mL (NDC 63323-493-91)

    Estimated recovery: TBD

    NDC 63323-493-91Reverified

    Unavailable

  • 15 mg/1 mL

    Xylocaine, Injection, 15 mg/1 mL (NDC 63323-493-97)

    Estimated recovery: TBD

    NDC 63323-493-97Reverified

    Unavailable

  • 20 mg/1 mL

    Xylocaine, Injection, 20 mg/1 mL (NDC 63323-486-57)

    Next release November 2026. Check wholesalers for inventory.

    NDC 63323-486-57Revised

    Unavailable

  • 20 mg/1 mL

    Xylocaine, Injection, 20 mg/1 mL (NDC 63323-496-97)

    Estimated recovery: TBD

    NDC 63323-496-97Reverified

    Unavailable

  • 5 mg/1 mL

    Xylocaine, Injection, 5 mg/1 mL (NDC 63323-484-57)

    Estimated recovery: TBD

    NDC 63323-484-57Reverified

    Unavailable

  • 10 mg/1 mL

    Lidocaine Hydrochloride In Plastic Container, Injection, 10 mg/1 mL (NDC 63323-201-02)

    Check wholesalers for inventory

    NDC 63323-201-02Reverified

    Available

  • 20 mg/1 mL

    Lidocaine Hydrochloride, Injection, 20 mg/1 mL (NDC 63323-202-02)

    Check wholesalers for inventory

    NDC 63323-202-02Reverified

    Available

  • 10 mg/1 mL

    Xylocaine, Injection, 10 mg/1 mL (NDC 63323-485-27)

    Check wholesalers for inventory

    NDC 63323-485-27Reverified

    Available

  • 10 mg/1 mL

    Xylocaine, Injection, 10 mg/1 mL (NDC 63323-492-27)

    Check wholesalers for inventory

    NDC 63323-492-27Reverified

    Available

  • 10 mg/1 mL

    Xylocaine, Injection, 10 mg/1 mL (NDC 63323-492-37)

    Check wholesalers for inventory

    NDC 63323-492-37Reverified

    Available

  • 10 mg/1 mL

    Xylocaine, Injection, 10 mg/1 mL (NDC 63323-492-57)

    Check wholesalers for inventory

    NDC 63323-492-57Reverified

    Available

  • 20 mg/1 mL

    Xylocaine, Injection, 20 mg/1 mL (NDC 63323-486-17)

    Check wholesalers for inventory

    NDC 63323-486-17Reverified

    Available

  • 20 mg/1 mL

    Xylocaine, Injection, 20 mg/1 mL (NDC 63323-486-27)

    Check wholesalers for inventory

    NDC 63323-486-27Reverified

    Available

  • 20 mg/1 mL

    Xylocaine, Injection, 20 mg/1 mL (NDC 63323-495-07)

    Check wholesalers for inventory

    NDC 63323-495-07Reverified

    Available

  • 20 mg/1 mL

    Xylocaine, Injection, 20 mg/1 mL (NDC 63323-495-27)

    Check wholesalers for inventory

    NDC 63323-495-27Reverified

    Available

  • 5 mg/1 mL

    Xylocaine, Injection, 5 mg/1 mL (NDC 63323-491-57)

    Check wholesalers for inventory

    NDC 63323-491-57Reverified

    Available

Hikma Pharmaceuticals USA, Inc.4 presentations · 1 unavailable · 3 available or not stated

Contact (FDA's listing): 800-631-2174

  • 10 mg/1 mL

    Lidocaine Hydrochloride, Preservative Free, Injection, 10 mg/1 mL (NDC 0143-9595-25)

    Product temporarily on backorder. Additional lots will be available in the November 2026 timeframe.

    NDC 0143-9595-25Revised

    Unavailable

  • 10 mg/1 mL

    Lidocaine Hydrochloride, Injection, 10 mg/1 mL (NDC 0143-9577-10)

    Additional lots are scheduled for manufacturing to meet demand. Product will be made available as it is released.

    NDC 0143-9577-10Reverified

    Available

  • 20 mg/1 mL

    Lidocaine Hydrochloride, Injection, 20 mg/1 mL (NDC 0143-9575-10)

    Additional lots are scheduled for manufacturing to meet demand. Product will be made available as it is released.

    NDC 0143-9575-10Reverified

    Available

  • 20 mg/1 mL

    Lidocaine Hydrochloride, Preservative Free, Injection, 20 mg/1 mL (NDC 0143-9594-25)

    Additional lots are scheduled to be manufactured. Product will be made available as it is released.

    NDC 0143-9594-25Reverified

    Available

Hospira, Inc., a Pfizer Company16 presentations · 2 unavailable · 1 limited · 13 available or not stated

Contact (FDA's listing): 844-646-4398

  • 250 mg/50 mL (0.5%; 5 mg/mL)

    Lidocaine Hydrochloride In Plastic Container, Injection, 250 mg/50 mL (0.5%; 5 mg/mL) (NDC 0409-4275-01)

    Next Delivery and Estimated Recovery: December 2028; Shortage per Manufacturer: Manufacturing Delay

    NDC 0409-4275-01Revised

    Unavailable

  • 20 mg/2 mL (1%; 10 mg/mL)

    Lidocaine Hydrochloride Preservative Free, Injection, 20 mg/2 mL (1%; 10 mg/mL) (NDC 0409-4713-32)

    Next Delivery and Estimated Recovery: March 2027; Shortage per Manufacturer: Manufacturing Delay

    NDC 0409-4713-32Revised

    Unavailable

  • 100 mg/5mL (2%,20 mg/1 mL) Syringes

    Lidocaine Hydrochloride Preservative Free In Plastic Container, Injection, 100 mg/5mL (2%,20 mg/1 mL) Syringes (NDC 0409-1323-05)

    Limited Supply Available. Next Delivery: January 2027; Estimated Recovery: March 2027; Shortage per Manufacturer: Manufacturing Delay

    NDC 0409-1323-05Revised

    Limited Availability

  • 1,000 mg/50 mL (2%; 20 mg/mL)

    Lidocaine Hydrochloride In Plastic Container, Injection, 1,000 mg/50 mL (2%; 20 mg/mL) (NDC 0409-4277-02)

    NDC 0409-4277-02Reverified

    Available

  • 200 mg/20 mL (1%; 10 mg/mL)

    Lidocaine Hydrochloride In Plastic Container, Injection, 200 mg/20 mL (1%; 10 mg/mL) (NDC 0409-4276-01)

    NDC 0409-4276-01Reverified

    Available

  • 400 mg/20 mL (2%; 20 mg/mL)

    Lidocaine Hydrochloride In Plastic Container, Injection, 400 mg/20 mL (2%; 20 mg/mL) (NDC 0409-4277-01)

    NDC 0409-4277-01Reverified

    Available

  • 500 mg/50 mL (1%; 10 mg/mL)

    Lidocaine Hydrochloride In Plastic Container, Injection, 500 mg/50 mL (1%; 10 mg/mL) (NDC 0409-4276-02)

    NDC 0409-4276-02Reverified

    Available

  • 50 mg/5mL (1%, 10 mg/1 mL) Syringes

    Lidocaine Hydrochloride Preservative Free In Plastic Container, Injection, 50 mg/5mL (1%, 10 mg/1 mL) Syringes (NDC 0409-9137-05)

    NDC 0409-9137-05Reverified

    Available

  • 200 mg/5 mL (4%; 40 mg/mL)

    Lidocaine Hydrochloride Preservative Free, Injection, 200 mg/5 mL (4%; 40 mg/mL) (NDC 0409-4283-01)

    NDC 0409-4283-01Reverified

    Available

  • 300 mg/20 mL (1.5%; 15 mg/mL)

    Lidocaine Hydrochloride Preservative Free, Injection, 300 mg/20 mL (1.5%; 15 mg/mL) (NDC 0409-4776-01)

    NDC 0409-4776-01Reverified

    Available

  • 50 mg/5 mL (1%; 10 mg/mL)

    Lidocaine Hydrochloride Preservative Free, Injection, 50 mg/5 mL (1%; 10 mg/mL) (NDC 0409-4713-02)

    NDC 0409-4713-02Reverified

    Available

  • 100 mg/5 mL (2%; 20 mg/mL)

    Lidocaine Hydrochloride, Injection, 100 mg/5 mL (2%; 20 mg/mL) (NDC 0409-2066-05)

    NDC 0409-2066-05Reverified

    Available

  • 200 mg/10 mL (2%; 20 mg/mL)

    Lidocaine Hydrochloride, Injection, 200 mg/10 mL (2%; 20 mg/mL) (NDC 0409-4282-02)

    NDC 0409-4282-02Reverified

    Available

  • 250 mg/50 mL (0.5%; 5 mg/mL)

    Lidocaine Hydrochloride, Injection, 250 mg/50 mL (0.5%; 5 mg/mL) (NDC 0409-4278-01)

    NDC 0409-4278-01Reverified

    Available

  • 300 mg/30 mL (1%; 10 mg/mL)

    Lidocaine Hydrochloride, Injection, 300 mg/30 mL (1%; 10 mg/mL) (NDC 0409-4279-02)

    NDC 0409-4279-02Reverified

    Available

  • 40 mg/2 mL (2%; 20 mg/mL)

    Lidocaine Hydrochloride, Injection, 40 mg/2 mL (2%; 20 mg/mL) (NDC 0409-4282-01)

    NDC 0409-4282-01Reverified

    Available

Huons Co., Ltd. (South Korea)1 presentation · 1 unavailable

Contact (FDA's listing): intbiz@huons.com

  • 10 mg/1 mL

    Lidocaine Hydrochloride, Injection, 10 mg/1 mL (NDC 73293-0001-2)

    Estimated recovery: TBD

    NDC 73293-0001-2Reverified

    Unavailable

Spectra Medical Devices, LLC1 presentation · 1 unavailable

Contact (FDA's listing): 978-657-0889 ext. 5231

  • 10 mg/1 mL

    Lidocaine Hydrochloride, Injection, 10 mg/1 mL (NDC 65282-1605-1)

    Estimated recovery: TBD

    NDC 65282-1605-1Reverified

    Unavailable

Amphastar Pharmaceuticals, Inc.1 presentation · 1 available or not stated

Contact (FDA's listing): 800-423-4136

  • 20 mg/1 mL

    Lidocaine Hydrochloride, Injection, 20 mg/1 mL (NDC 76329-3390-1)

    NDC 76329-3390-1Reverified

    Available

Anthea Pharma6 presentations · 6 available or not stated

Contact (FDA's listing): Avenacy, LLC: 877-283-6229

  • 50 mg/5 mL

    Lidocaine Hydochloride, Injection, 50 mg/5 mL (NDC 83634-653-05)

    Distributed by Avenacy, LLC

    NDC 83634-653-05Reverified

    Available

  • 100 mg/10 mL

    Lidocaine Hydrochloride, Injection, 100 mg/10 mL (NDC 83634-651-10)

    Distributed by Avenacy, LLC

    NDC 83634-651-10Reverified

    Available

  • 20 mg/2 mL

    Lidocaine Hydrochloride, Injection, 20 mg/2 mL (NDC 83634-653-02)

    Distributed by Avenacy, LLC

    NDC 83634-653-02Reverified

    Available

  • 200 mg/20 mL

    Lidocaine Hydrochloride, Injection, 200 mg/20 mL (NDC 83634-651-20)

    Distributed by Avenacy, LLC

    NDC 83634-651-20Reverified

    Available

  • 300 mg/30 mL

    Lidocaine Hydrochloride, Injection, 300 mg/30 mL (NDC 83634-653-30)

    Distributed by Avenacy, LLC

    NDC 83634-653-30Reverified

    Available

  • 500 mg/50 mL

    Lidocaine Hydrochloride, Injection, 500 mg/50 mL (NDC 83634-651-50)

    Distributed by Avenacy, LLC

    NDC 83634-651-50Reverified

    Available

B. Braun Medical Inc.3 presentations · 3 available or not stated

Contact (FDA's listing): 800-227-2862

  • 5 g/100 mL; .4 g/100 mL

    Lidocaine Hydrochloride And Dextrose, Injection, 5 g/100 mL; .4 g/100 mL (NDC 0264-9594-10)

    NDC 0264-9594-10Reverified

    Available

  • 5 g/100 mL; .4 g/100 mL

    Lidocaine Hydrochloride And Dextrose, Injection, 5 g/100 mL; .4 g/100 mL (NDC 0264-9594-20)

    NDC 0264-9594-20Reverified

    Available

  • 5 g/100 mL; .8 g/100 mL

    Lidocaine Hydrochloride And Dextrose, Injection, 5 g/100 mL; .8 g/100 mL (NDC 0264-9598-20)

    NDC 0264-9598-20Reverified

    Available

Baxter Healthcare2 presentations · 2 available or not stated

Contact (FDA's listing): 888-229-0001

  • 4 mg/1 mL

    Lidocaine Hydrochloride And Dextrose, Injection, 4 mg/1 mL (NDC 0338-0409-03)

    NDC 0338-0409-03Reverified

    Available

  • 8 mg/1 mL

    Lidocaine Hydrochloride And Dextrose, Injection, 8 mg/1 mL (NDC 0338-0411-02)

    NDC 0338-0411-02Reverified

    Available

What the manufacturers told FDA

  • Eugia US LLC · ‘On backorder. Recovery: TBD. Check wholesalers for inventory’ · updated Oct 2026
  • Eugia US LLC · ‘On backorder. Recovery: late October 2026; Check wholesalers for inventory’ · updated Oct 2026
  • Eugia US LLC · ‘On backorder. Recovery: late-November 2026; Check wholesalers for inventory’ · updated Oct 2026
  • Eugia US LLC · ‘On backorder. Recovery: mid-November 2026; Check wholesalers for inventory’ · updated Oct 2026
  • Fresenius Kabi USA, LLC · ‘Estimated recovery: TBD’ · updated Oct 2026

More on FDA ↗ (opens in a new tab)

Reason for the shortage (FDASIA)

  • Demand increase for the drug
  • Other

As reported by the manufacturer under the Food and Drug Administration Safety and Innovation Act.

Other products with the same ingredient and form

A discontinuation “does not necessarily create a shortage” (FDA).

  • Hospira, Inc., a Pfizer Company told FDA it will discontinue Lidocaine Hydrochloride (posted ).

    “Discontinuation of the manufacture of the drug”

    FDA listing: Lidocaine Hydrochloride Injection

Alternatives

FDA lists none: “Providing a list of alternative drug products for a drug in shortage is part of the ‘practice of medicine.’ FDA does not regulate the practice of medicine.” Your prescriber or pharmacist can talk through options with you. ASHP also tracks shortages and suggested alternatives (different criteria) ↗ (opens in a new tab)

Questions

Is Xylocaine in shortage?
Yes. As of Oct 24, 2026, FDA lists Lidocaine Hydrochloride Injection as currently in shortage: 65 presentations, 19 unavailable and 1 limited.
When will the Xylocaine shortage end?
FDA gives no end date. 10 presentations carry a manufacturer’s own estimate, quoted on this page with its date.
Does FDA list alternatives to Xylocaine?
No. FDA calls a list of alternatives part of the ‘practice of medicine’. Ask your pharmacist or prescriber.